KALV
KALVISTA PHARMAC (KALV)
NASDAQ
$26.95+$0.006 (+0.02%)
Price as of Jun 03, 2026 7:12 PM EDT
  • $1.4B
    Market Cap
  • 101.80%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 88
Valuation
KALV
vs History
vs S&P 500
Profitability
0
Growth
1
Low Earnings Volatility
1

Momentum Score

Score: 77
Valuation
KALV
vs History
vs S&P 500
3-Month Momentum
63.70%
12-Month Momentum
106.27%
3-Month Risk Adjusted Momentum
136.98%
12-Month Risk Adjusted Momentum
147.18%

True Yield

N/A
Valuation
KALV
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.08%
Net Debt Paydown Yield
-0.03%

Financial Health Score

Score: 100
Valuation
KALV
vs History
vs S&P 500
Ohlson's O-Score
7